Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

被引：0
|
作者：
Sophie Lehn
Nicholas P Tobin
Andrew H Sims
Olle Stål
Karin Jirström
Håkan Axelson
Göran Landberg
机构：
[1] Department of Laboratory Medicine,Center for Molecular Pathology
[2] Lund University,Cancer Center Karolinska
[3] Skåne University Hospital,Applied Bioinformatics of Cancer
[4] Karolinska Institutet and University Hospital,Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences
[5] University of Edinburgh Cancer Research Centre,Department of Clinical Sciences
[6] Linköping University,Translational Cancer Research
[7] Division of Pathology,Sahlgrenska Cancer Center
[8] Lund University,Breakthrough Breast Cancer Unit, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research
[9] Skåne University Hospital,undefined
[10] Department of Laboratory Medicine,undefined
[11] Lund University,undefined
[12] University of Gothenburg,undefined
[13] University of Manchester,undefined
来源：
BMC Cancer | / 14卷
关键词：
Yes-associated protein; Breast cancer; Estrogen receptor; Luminal A; 11q deletion; Tamoxifen response; Independent prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
    Lehn, Sophie
    Tobin, Nicholas P.
    Sims, Andrew H.
    Stal, Olle
    Jirstrom, Karin
    Axelson, Hakan
    Landberg, Goran
    BMC CANCER, 2014, 14
  • [2] Expression of Yes-associated protein (YAP) in metastatic breast cancer
    Kim, Hye Min
    Jung, Woo Hee
    Koo, Ja Seung
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11248 - 11257
  • [3] Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer
    Wang, Xiaodan
    Su, Lili
    Ou, Qishui
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (08) : 1227 - 1234
  • [4] Expression characteristics of the yes-associated protein in breast cancer: A meta-analysis
    Li, Lan
    Luo, Jin
    Fang, Jing-Yi
    Zhang, Rui
    Ma, Jian-Bo
    Zhu, Zheng-Peng
    MEDICINE, 2022, 101 (34) : E30176
  • [5] Expression of Yes-associated protein (YAP) in breast phyllodes tumor
    Kim, Sang Kyum
    Jung, Woo Hee
    Koo, Ja Seung
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5997 - 6005
  • [6] Yes-associated Protein Is Not an Independent Prognostic Marker in Breast Cancer
    Sheen-Chen, Shyr-Ming
    Huang, Chun-Ying
    Tsai, Ching-Hua
    Liu, Yueh-Wei
    Wu, Shih-Chung
    Huang, Chao-Cheng
    Eng, Hock-Liew
    Chan, Yi-Chia
    Ko, Sheung-Fat
    Tang, Rei-Ping
    ANTICANCER RESEARCH, 2012, 32 (08) : 3321 - 3325
  • [7] Expression of yes-associated protein, β-catenin and smoothened, and their clinical significance in invasive breast cancer
    Liu, Pengju
    Zeng, Jianfeng
    Yang, Gaohua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (06)
  • [8] Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues
    Cao, Lanqing
    Sun, Ping-Li
    Yao, Min
    Jia, Meng
    Gao, Hongwen
    HUMAN PATHOLOGY, 2017, 68 : 166 - 174
  • [9] Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
    Cao, Liyu
    Zhang, Cong
    Wu, Qingqing
    Bai, Zhenzhen
    Chen, Jing
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [10] Expression of Yes-Associated Protein (YAP) in Breast Cancer is Associated with Cancer Stem Cell Markers and its Inhibition Improves the Response to Hormonal Therapy
    Guimei, Maha
    Alrouh, Sana
    Saber-Ayad, Maha
    Wardeh, Yazan
    Bakkour, Tala
    El Serafi, Ahmed
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 164 - 164
12345